These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12494203)

  • 1. [Assessment of efficacy and safety of nebivolol in patients with stable effort angina].
    Makolkin VI; Sulimov VA; Gavrilov YV; Petriĭ VV; Aksel'rod AS; Buval'tsev VI
    Kardiologiia; 2002; 42(2):24-7. PubMed ID: 12494203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardioselective beta-adrenoblockers in patients with stable angina pectoris. Comparison of efficacy and safety].
    Dupliakov DV; Glukhova VL; Vozhdaeva ZI; Golovina GA
    Ter Arkh; 2006; 78(9):43-8. PubMed ID: 17076224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes].
    Makolkin VI; Akhmedova OO; Buval'tsev VI; Gavrilov IuV; Petriĭ VV
    Kardiologiia; 2003; 43(2):40-3. PubMed ID: 12891271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.
    Ruf G; Trenk D; Jähnchen E; Roskamm H
    Int J Cardiol; 1994 Mar; 43(3):279-85. PubMed ID: 7910155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-immunological disorders in patients with ischemic heart disease combined with metabolic syndrome and modulating effect of nebivolol for their correction].
    Tepliakov AT; Bolotskaia LA; Vdovina TV; Stepacheva TA; Kuznetsova AV
    Ter Arkh; 2008; 80(12):44-52. PubMed ID: 19227907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Saatsaki M; Diakakis GF; Chlouverakis GI; Vardas PE
    Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiischemic and metabolic effects of nebivolol and metaprolol CR/XL (betalok ZOK) in patients with postinfarction heart dysfunction].
    Tepliakov AT; Kuznetsova AV; Stepacheva TA; D'iakova ML; Shilov SN; Bolotskaia LA
    Klin Med (Mosk); 2005; 83(4):56-9. PubMed ID: 15941146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nebivolol in the treatment of ischemic heart disease patients with chronic heart failure].
    Evdokimova AG; Radzevich AE; Tereshchenko OI; Pichugina TA; Kovalenko EV
    Kardiologiia; 2004; 44(2):15-8. PubMed ID: 15029131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting].
    Tepliakov AT; Kuznetsova AV; Lukinov AV; Levshin AV
    Ter Arkh; 2007; 79(12):38-43. PubMed ID: 18220029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
    Conraads VM; Metra M; Kamp O; De Keulenaer GW; Pieske B; Zamorano J; Vardas PE; Böhm M; Dei Cas L
    Eur J Heart Fail; 2012 Feb; 14(2):219-25. PubMed ID: 22147202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
    Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency].
    Boutelant S; Lechat P; Komajda M; Isnard R; Salloum J; Gagey S; Bertholon JF; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):863-70. PubMed ID: 1358044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure.
    Brune S; Schmidt T; Tebbe U; Kreuzer H
    Angiology; 1990 Sep; 41(9 Pt 1):696-701. PubMed ID: 1977335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study.
    Brehm BR; Wolf SC; Görner S; Buck-Müller N; Risler T
    Eur J Heart Fail; 2002 Dec; 4(6):757-63. PubMed ID: 12453547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
    Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of safety and antihypertensive efficacy of a cardioselective beta-blocker nebivolol in patients with hypertension and concomitant chronic obstructive bronchitis].
    Iakushin SS; Okorokov VG; Liferov RA; Fomina VA; Ivanova GO
    Kardiologiia; 2002; 42(11):36-9. PubMed ID: 12494034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.